Company / R&D Expense
ESTABLISHMENT LABS HOLDINGS INC. R&D Expense History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$20.2M
FY2025
5-year range
$15.0M / $26.4M
FY2021-FY2025
Trend
+2.7%
vs FY2024
Sector context
#97 of 110
Health Care
What the data says
ESTABLISHMENT LABS HOLDINGS INC.'s r&d expense of $20M is lower than 88% of companies in the Health Care sector (FY2025). Declined from $26M to $20M over the past 2 years.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of +6.2%.
Declined from $26M to $20M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -0.0%
- 5-Year CAGR
- +6.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 110This company $20.2M Sector average $298.2M
▼
-93.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.2%, indicating consistent growth.
- In FY2025, r&d expense increased 2.7% year-over-year.
- Ranks #97 out of 110 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.56 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.2M | +2.7% |
| FY2024 | $19.7M | -25.4% |
| FY2023 | $26.4M | +30.4% |
| FY2022 | $20.3M | +35.2% |
| FY2021 | $15.0M | +0.0% |
| FY2020 | $15.0M | +18.2% |
| FY2019 | $12.7M | +84.8% |
| FY2018 | $6.9M | +0.0% |
| FY2017 | $6.9M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026